Mettler-Toledo International, I (MTD) Stock Price & How to Invest

Mettler-Toledo International Inc. (NYSE: MTD) designs, manufactures, and services precision instruments used to weigh, measure, and analyze materials. It reports across three segments: Laboratory (roughly 55% of sales, including balances, pipettes, pH meters, titrators, thermal analysis, and automated chemistry serving pharma, biotech, and academic customers), Industrial (roughly 40%, including industrial weighing, terminals, and automated product-inspection systems like metal detectors and X-ray for food and manufacturing lines), and Food Retail (roughly 5%, weighing and labeling systems for supermarkets). The business is geographically diversified, with the Americas around 37% of sales, Europe around 27%, China around 16%, and the rest of the world the remainder. A large share of revenue is recurring service and consumables, which cushions the equipment cycle, and the company holds a dominant position (over half) of the global market for laboratory balances.

The investment picture rests on quality rather than rapid growth. Mettler-Toledo grows sales in the low-to-mid single digits in local currency but has compounded earnings per share much faster through steady margin expansion, disciplined pricing, its high-margin service business, and one of the most aggressive share-buyback programs in the sector (it pays no dividend and returns essentially all free cash flow via repurchases, shrinking the share count for years). Full-year 2025 revenue was about $4.0 billion with net income near $869 million and reported EPS around $42, and Q1 2026 delivered adjusted EPS of $8.91 with management reiterating roughly 4% local-currency sales growth and raising full-year adjusted EPS guidance to the $46.05 to $46.70 range. The stock trades at a premium valuation reflecting that consistency, so the debate centers on whether end-market demand (especially China and pharma capital spending) reaccelerates enough to justify the multiple.

Mettler-Toledo carries a premium valuation (a trailing P/E around 30x), so any disappointment in growth or margins can compress the multiple sharply. Its end markets are cyclical and capital-spending sensitive: soft pharma and biotech budgets, weak Chinese industrial demand, or a broad manufacturing slowdown directly pressure new-instrument orders. With substantial international sales, a stronger U.S. dollar is a recurring headwind to reported revenue and earnings. The Food Retail segment has shown pockets of weakness, including double-digit U.S. declines in early 2026. Finally, growth is structurally modest (low-single-digit local-currency sales), so the earnings story depends heavily on continued margin expansion and buybacks rather than top-line acceleration, which limits the margin for error if either lever stalls.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Mettler-Toledo International, I's investor relations page or your broker.

• Revenue (FY2025): ~$4.0 billion (up ~4%)
• Net Income (FY2025): ~$869 million
• Reported EPS (FY2025): ~$42
• FY2026 Adjusted EPS Guidance: ~$46.05 to ~$46.70
• Market Capitalization: ~$26 billion
• P/E Ratio (TTM): ~30x (forward ~28x)

Mettler-Toledo trades at a premium multiple (a trailing P/E near 30x) that sits between peers like Thermo Fisher and Danaher, reflecting its consistency and margin quality. It pays no dividend, returning capital entirely through buybacks that steadily reduce the share count. The valuation prices in continued mid-single-digit sales growth converting into high-single-digit to low-double-digit EPS growth.

There are three common ways to get MTD exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic basket, so MTD sits alongside other stocks that express the same thesis.

Walnut takes the basket route. Describe a thesis where MTD fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

Mettler-Toledo is a wide-moat, high-margin precision-instruments compounder trading at a premium life-sciences-tools multiple, so the investment picture is a bet on durable pricing power, a large recurring service base, and aggressive buybacks continuing to grow earnings faster than its low-single-digit sales growth.

Whether MTD is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is MTD a buy?, and where the stock could go from here in the MTD stock forecast.

For income investors, whether MTD pays a dividend and how the payout looks is covered in does MTD pay a dividend?